<DOC>
	<DOCNO>NCT01153984</DOCNO>
	<brief_summary>This open-label , single-arm , multi-center study evaluate effect Tarceva ( erlotinib ) progression-free survival incidence type biomarkers patient advance and/or metastatic non-small cell lung cancer Epidermal Growth Factor Receptor ( EGFR ) positive mutation . Eligible patient receive Tarceva 150mg po daily . The anticipated time study treatment progression unacceptable toxicity .</brief_summary>
	<brief_title>A Study Tarceva ( Erlotinib ) Patients With Advanced and/or Metastatic Non-small Cell Lung Cancer With EGFR Positive Mutation ( BIOTEC )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>Adult patient , &gt; =18 year age Histological document adenocarcinoma , locally advanced stage IIIB , metastatic stage IV recurrent nonsquamous nonsmall cell lung cancer ( NSCLC ) Eastern Cooperative Oncology Group ( ECOG ) performance status 01 Life expectancy &gt; =12 week Evidence disease least one measurable disease criterion evaluate Response Evaluation Criteria Solid Tumors ( RECIST ) Adequate haematological , liver renal function Known hypersensitivity erlotinib excipients Squamous nonsmall cell small cell tumor absence histological report Neoadjuvant/adjuvant chemotherapy within 6 month prior enrolment Prior exposure inhibitor Epidermal Growth Factor Receptor ( EGFR ) Prior chemotherapy treatment another systemic anticancer agent treatment patient 's current stage disease Any significant ophthalmologic abnormality , especially severe dry eye syndrome , keratoconjunctivitis sicca , Sj√∂grens syndrome , severe exposure keratitis disorder likely increase risk corneal epithelial lesion Radical radiotherapy curative intent within 28 day prior enrolment Any active noncontrolled systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>